Clene Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Clene Inc.
- Former names
- Chelsea Worldwide Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Salt Lake City
- Headquarters state / province
- Utah
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CLNN
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001822791
- EIN
- 85-2828339
Board of directors
-
Alison Mosca · DirectorSince 2023
-
Arjun Jj Desai · DirectorSince 2023
-
Chidozie Ugwumba · DirectorSince 2023
-
David J. Matlin · DirectorSince 2023
-
John Henry Stevens · DirectorSince 2023
-
Jonathon Gay · DirectorSince 2023
-
Matthew Kiernan · DirectorSince 2023
-
Reed N. Wilcox · DirectorSince 2024
-
Robert Dee Etherington · Director · President & CEOSince 2023
-
Shalom Jacobovitz · DirectorSince 2023
-
Vallerie McLaughlin · DirectorSince 2023
Chief executives
Robert Dee Etherington
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of May 18, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
78.3%
-
79.0%
-
83.2%
Board connections
3 of this board's directors also sit on 3 other boards.
- via Arjun Jj Desai and David J. Matlin
- via Arjun Jj Desai
- via Chidozie Ugwumba
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $216,665
- 1 purchase by 1 insider
- Sold, last 12 months
- $5,781,161
- 62 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 16, 2026 | Alison Mosca Director, 10% owner | Grant or award | +198,171 | $3.28 | $650,001 |
| Sep 16, 2026 | Robert Dee Etherington Director, Officer (President & CEO) | Grant or award | +15,244 | $3.28 | $50,000 |
| Sep 16, 2026 | David J. Matlin Director | Grant or award | +434,451 | $3.28 | $1,424,999 |
| May 12, 2026 | Chidozie Ugwumba 10% owner | Open-market sale | −73,296 | $6.20 | $454,435 |
| May 11, 2026 | Chidozie Ugwumba 10% owner | Open-market sale | −22,177 | $6.75 | $149,695 |
| May 4, 2026 | Chidozie Ugwumba 10% owner | Open-market sale | −72,884 | $6.80 | $495,611 |
| May 1, 2026 | Chidozie Ugwumba 10% owner | Open-market sale | −5,795 | $6.01 | $34,828 |
| Apr 30, 2026 | Chidozie Ugwumba 10% owner | Open-market sale | −5,736 | $6.08 | $34,875 |
| Apr 29, 2026 | Chidozie Ugwumba 10% owner | Open-market sale | −12,170 | $5.63 | $68,517 |
| Apr 28, 2026 | Chidozie Ugwumba 10% owner | Open-market sale | −1,591 | $5.90 | $9,387 |
| Apr 21, 2026 | Chidozie Ugwumba 10% owner | Open-market sale | −61,345 | $6.14 | $376,658 |
| Apr 20, 2026 | Chidozie Ugwumba 10% owner | Open-market sale | −4,318 | $6.12 | $26,426 |
| Apr 17, 2026 | Chidozie Ugwumba 10% owner | Open-market sale | −25,040 | $6.43 | $161,007 |
| Apr 16, 2026 | Chidozie Ugwumba 10% owner | Open-market sale | −7,748 | $6.40 | $49,587 |
| Apr 15, 2026 | Chidozie Ugwumba 10% owner | Open-market sale | −6,374 | $6.48 | $41,304 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.